Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xywav in Narcolepsy with Cataplexy
NCT03030599Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Mar 2017
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of sodium oxybate + calcium oxybate + potassium oxybate + magnesium oxybate in narcolepsy, sponsored by Jazz Pharmaceuticals plc. Started Mar 2017; status: completed.
02
Drugs
sodium oxybate + calcium oxybate + potassium oxybate + magnesium oxybate
03
Conditions
narcolepsy
Beyond the preview
Go deeper on NCT03030599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03030599.